Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Detoxification processes comprise a series of highly conserved biochemical pathways that convert lipophilic (fat-soluble) toxins into more hydrophilic (water-soluble) forms, facilitating their excretion via urine, bile, or sweat. The liver is the central organ involved, utilizing sequential "phase I" and "phase II" reactions. Phase I (primarily mediated by cytochrome P450 enzymes) modifies toxins to generate more reactive intermediates, while phase II (conjugation enzymes such as glutathione-S-transferases, UDP-glucuronosyltransferases, and others) neutralizes these intermediates by attaching polar groups, facilitating their elimination. Phase III involves transport proteins moving conjugated toxins out of cells for excretion. Genetic variability, diet, and disease states can substantially impact the efficacy and balance of these processes. Defects or imbalances in detoxification pathways are implicated in diverse diseases, but "detoxification processes" as a whole is not an actionable molecular target[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Detoxification processes.